BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9702592)

  • 21. Screening voided urine for Chlamydia trachomatis in asymptomatic adolescent females.
    Svensson LO; Mares I; Mårdh PA; Olsson SE
    Acta Obstet Gynecol Scand; 1994 Jan; 73(1):63-6. PubMed ID: 8304030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.
    Michel CE; Sonnex C; Carne CA; White JA; Magbanua JP; Nadala EC; Lee HH
    J Clin Microbiol; 2007 May; 45(5):1395-402. PubMed ID: 17376879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ELISA to detect Chlamydia trachomatis antigen in urine samples from arthritis patients.
    Wollenhaupt J; Hartmann F; Köhler L; Kuipers JG; Nettelnbreker E; Frosch M; Zeidler H
    Clin Exp Rheumatol; 1997; 15(2):169-74. PubMed ID: 9196869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Chlamydia trachomatis cervical infection by urine tests among adolescents clinics.
    Beck-Sague CM; Farshy CE; Jackson TK; Guillory L; Edelkind D; Bullard JC; Urdez EA; Jones B; Francis K; Sievert A; Morse SA; Black CM
    J Adolesc Health; 1998 Mar; 22(3):197-204. PubMed ID: 9502006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of direct fluorescent antibody technique in detecting Chlamydia trachomatis in sexually transmitted infections clinics.
    Dajek Z; Selibórska Z; Wiecko-Jankowska E
    Med Wieku Rozwoj; 2005; 9(1):111-5. PubMed ID: 16082072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of direct immunofluorescent staining and an enzyme-linked immunoabsorbent assay for identifying Chlamydia trachomatis in cervical and urethral specimens.
    Wiesmeier E; Bruckner DA; Malotte CK; Downie A
    J Reprod Med; 1989 Aug; 34(8):517-9. PubMed ID: 2681749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a direct fluorescent antibody test for detection of Chlamydia trachomatis in endocervical specimens. Brief report.
    Dereli D; Ertem E; Serter D; Yüce K
    APMIS; 1991 Oct; 99(10):961-4. PubMed ID: 1930969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-void urine testing for Chlamydia trachomatis by polymerase chain reaction in asymptomatic women.
    Paukku M; Puolakkainen M; Apter D; Hirvonen S; Paavonen J
    Sex Transm Dis; 1997 Jul; 24(6):343-6. PubMed ID: 9243741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia.
    Spasovski MS; Simjanovska LJ; Taleski V; Petrova N; Lazetic L; Popeska Z; Gaydos CA; Quinn TC; Efremov GD
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):427-30. PubMed ID: 15987287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of genitourinary tract Chlamydia trachomatis infection in pregnant women by ligase chain reaction assay.
    Andrews WW; Lee HH; Roden WJ; Mott CW
    Obstet Gynecol; 1997 Apr; 89(4):556-60. PubMed ID: 9083312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine.
    Berg ES; Anestad G; Moi H; Størvold G; Skaug K
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):727-31. PubMed ID: 9405941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation of Chlamydia trachomatis positivity in women with and without gynecologic complaints by cytologic and direct immunofluorescence methods].
    Ozdağ D; Us D; Demirezen S; Beksaç S
    Mikrobiyol Bul; 2007 Jan; 41(1):51-61. PubMed ID: 17427552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid communication: Cervical Chlamydia trachomatis in women at low risk for infection.
    Cheema MA; Rahman MU; Whittum-Hudson JA; Hudson AP
    Am J Med Sci; 2000 Feb; 319(2):123-5. PubMed ID: 10698098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vulval swabs as alternative specimens for ligase chain reaction detection of genital chlamydial infection in women.
    Stary A; Najim B; Lee HH
    J Clin Microbiol; 1997 Apr; 35(4):836-8. PubMed ID: 9157137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men.
    Sanders JW; Hook EW; Welsh LE; Shepherd ME; Quinn TC
    J Clin Microbiol; 1994 Jan; 32(1):24-7. PubMed ID: 8126190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males.
    Leonardi GP; Seitz M; Edstrom R; Cruz J; Costello P; Szabo K
    J Clin Microbiol; 1992 Nov; 30(11):2793-6. PubMed ID: 1452648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DFA, EIA, PCR, LCR and other technologies: what tests should be used for diagnosis of chlamydia infections?
    Schachter J
    Immunol Invest; 1997; 26(1-2):157-61. PubMed ID: 9037620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting.
    Oh MK; Richey CM; Pate MS; Brown PR; Hook EW
    J Adolesc Health; 1997 Aug; 21(2):80-6. PubMed ID: 9248931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a commercial polymerase chain reaction assay for Chlamydia trachomatis and suggestions for improving sensitivity.
    Thomas BJ; MacLeod EJ; Taylor-Robinson D
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):719-23. PubMed ID: 8565995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations.
    Herrmann B; Espinoza F; Villegas RR; Smith GD; Ramos A; Egger M
    Genitourin Med; 1996 Feb; 72(1):20-6. PubMed ID: 8655162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.